Platelet transfusion improves liver function in patients with chronic liver disease and cirrhosis

Tohoku Journal of Experimental Medicine

Volumn 229, Issue 3, 2013, Pages 213-220

  Maruyama, Takehito ^a   Murata, Soichiro ^b   Takahashi, Kazuhiro ^a   Tamura, Takafumi ^a   Nozaki, Reiji ^a   Ikeda, Naoya ^a   Fukunaga, Kiyoshi ^a   Oda, Tatsuya ^a   Sasaki, Ryoko ^a   Ohkohchi, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Chronic liver disease; Liver cirrhosis; Liver function; Platelet transfusion; Platelet transfusion refractoriness

Indexed keywords

ALBUMIN; CHOLINESTERASE; HYALURONIC ACID; THROMBOCYTE CONCENTRATE;

ADULT; ADVERSE OUTCOME; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; OUTCOME ASSESSMENT; PRURITUS; THERAPY EFFECT; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLATELET COUNT; PLATELET TRANSFUSION;

EID: 84876338539     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.229.213     Document Type: Article

References (40)

1. Assoian, R.K., Komoriya, A., Meyers, C.A., Miller, D.M. & Sporn, M.B. (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem., 258, 7155-7160.
2. Bashour, F.N., Teran, J.C. & Mullen, K.D. (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am. J. Gastroenterol., 95, 2936-2939.
3. Castera, L., Forns, X. & Alberti, A. (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol., 48, 835-847.
4. D'Amico, G., Garcia-Tsao, G. & Pagliaro, L. (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J. Hepatol., 44, 217-231.
5. Daly, P.A., Schiffer, C.A., Aisner, J. & Wiernik, P.H. (1980) Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA, 243, 435-438.
6. Diegelmann, R.F. & Evans, M.C. (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci., 9, 283-289.
7. Endo, Y. & Nakamura, M. (1992) The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br. J. Pharmacol., 105, 613-619.
8. Endo, Y. & Nakamura, M. (1993) Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor. Gen. Pharmacol., 24, 1039-1053.
9. Friedman, S.L. (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655-1669.
10. Giannini, E., Borro, P., Botta, F., Fumagalli, A., Malfatti, F., Podesta, E., Romagnoli, P., Testa, E., Chiarbonello, B., Polegato, S., Mamone, M. & Testa, R. (2002) Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J. Hepatol., 37, 572-577.
11. Heidelbaugh, J.J. & Sherbondy, M. (2006) Cirrhosis and chronic liver failure: part II. Complications and treatment. Am. Fam. Physician, 74, 767-776.
12. Ikeda, N., Murata, S., Maruyama, T., Tamura, T., Nozaki, R., Kawasaki, T., Fukunaga, K., Oda, T., Sasaki, R., Homma, M. & Ohkohchi, N. (2011) Platelet-derived adenosine 5′-triphosphate suppresses activation of human hepatic stellate cell: in vitro study. Hepatol. Res., 42, 91-102.
13. Kawasaki, T., Murata, S., Takahashi, K., Nozaki, R., Ohshiro, Y., Ikeda, N., Pak, S., Myronovych, A., Hisakura, K., Fukunaga, K., Oda, T., Sasaki, R. & Ohkohchi, N. (2010) Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J. Hepatol., 53, 648-654.
14. Klingemann, H.G., Self, S., Banaji, M., Deeg, H.J., Doney, K., Slichter, S.J., Thomas, E.D. & Storb, R. (1987) Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases. J. Haematol., 66, 115-121.
15. Kurata, Y., Shimizu, M., Okazaki, H. & Takemoto, S. (2007) Incidence of Nonhemolytic Transfusion Reaction due to Immnological Reactions. Japanese Journal of Transfusion and Cell Therapy, 53, 43-46.
16. Legler, T.J., Fischer, I., Dittmann, J., Simson, G., Lynen, R., Humpe, A., Riggert, J., Schleyer, E., Kern, W., Hiddemann, W. & Kohler, M. (1997) Frequency and causes of refractoriness in multiply transfused patients. Ann. Hematol., 74, 185-189.
17. Malik, R., Selden, C. & Hodgson, H. (2002) The role of nonparenchymal cells in liver growth. Semin. Cell. Dev. Biol., 13, 425-431.
18. Matsuo, R., Ohkohchi, N., Murata, S., Ikeda, O., Nakano, Y., Watanabe, M., Hisakura, K., Myronovych, A., Kubota, T., Narimatsu, H. & Ozaki, M. (2008) Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J. Surg. Res., 145, 279-286.
19. McHutchison, J.G., Dusheiko, G., Shiffman, M.L., Rodriguez-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S.C., Campbell, F.M., Theodore, D., Blackman, N., Jenkins, J. & Afdhal, N.H. (2007) Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N. Engl. J. Med., 357, 2227-2236.
20. Merion, R.M., Schaubel, D.E., Dykstra, D.M., Freeman, R.B., Port, F.K. & Wolfe, R.A. (2005) The survival benefit of liver transplantation. Am. J. Transplant., 5, 307-313.
21. Miyazono, K. & Takaku, F. (1989) Platelet-derived growth factors. Blood. Rev., 3, 269-276.
22. Mueller, A.R., Platz, K.P. & Kremer, B. (2004) Early postoperative complications following liver transplantation. Best. Pract. Res. Clin. Gastroenterol., 18, 881-900.
23. Murata, K., Ito, K., Yoneda, K., Shiraki, K., Sakurai, H. & Ito, M. (2008a) Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology, 55, 1407-1411.
24. Murata, K., Shiraki, K., Takase, K., Nakano, T. & Tameda, Y. (1996) Long term follow-up for patients with liver cirrhosis after partial splenic embolization. Hepatogastroenterology, 43, 1212-1217.
25. Murata, S., Hashimoto, I., Nakano, Y., Myronovych, A., Watanabe, M. & Ohkohchi, N. (2008b) Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann. Surg., 248, 821-828.
26. Murata, S., Ohkohchi, N., Matsuo, R., Ikeda, O., Myronovych, A. & Hoshi, R. (2007) Platelets promote liver regeneration in early period after hepatectomy in mice. World J. Surg., 31, 808-816.
27. Myronovych, A., Murata, S., Chiba, M., Matsuo, R., Ikeda, O., Watanabe, M., Hisakura, K., Nakano, Y., Kohno, K., Kawasaki, T., Hashimoto, I., Shibasaki, Y., Yasue, H. & Ohkohchi, N. (2008) Role of platelets on liver regeneration after 90% hepatectomy in mice. J. Hepatol., 49, 363-372.
28. Nakamura, M., Shibazaki, M., Nitta, Y. & Endo, Y. (1998) Translocation of platelets into Disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumour necrosis factor: the role of Kupffer cells. J. Hepatol., 28, 991-999.
29. Nakamura, T., Teramoto, H. & Ichihara, A. (1986) Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. USA, 83, 6489-6493.
30. Neuberger, J. & James, O. (1999) Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet, 354, 1636-1639.
31. Ohta, M., Nishizaki, T., Matsumoto, T., Shimabukuro, R., Sasaki, A., Shibata, K., Matsusaka, T. & Kitano, S. (2005) Analysis of risk factors for massive intraoperative bleeding during laparoscopic splenectomy. J. Hepatobiliary Pancreat. Surg., 12, 433-437.
32. Oka, Y. & Orth, D.N. (1983) Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J. Clin. Invest., 72, 249-259.
33. Patel, A.G., Parker, J.E., Wallwork, B., Kau, K.B., Donaldson, N., Rhodes, M.R., O'Rourke, N., Nathanson, L. & Fielding, G. (2003) Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy. Ann. Surg., 238, 235-240.
34. Porrett, P.M., Hsu, J. & Shaked, A. (2009) Late surgical complications following liver transplantation. Liver Transpl., 15 Suppl 2, S12-18.
35. Seeff, L.B., Everson, G.T., Morgan, T.R., Curto, T.M., Lee, W.M., Ghany, M.G., Shiffman, M.L., Fontana, R.J., Di Bisceglie, A.M., Bonkovsky, H.L. & Dienstag, J.L. (2010) Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin. Gastroenterol. Hepatol., 8, 877-883.
36. Stroncek, D.F. & Rebulla, P. (2007) Platelet transfusions. Lancet, 370, 427-438.
37. Takahashi, K., Kozuma, Y., Suzuki, H., Tamura, T., Maruyama, T., Fukunaga, K., Murata, S. & Ohkohchi, N. (2012) Human platelets promote liver regeneration with Kupffer cells in SCID mice. J. Surg. Res., Epub ahead of print.
38. Taylor, M.C., Greig, P.D., Detsky, A.S., McLeod, R.S., Abdoh, A. & Krahn, M.D. (2002) Factors associated with the high cost of liver transplantation in adults. Can. J. Surg., 45, 425-434.
39. The Trial to Reduce Alloimmunization to Platelets Study Group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N. Engl. J. Med., 337, 1861-1869.
40. Watanabe, M., Murata, S., Hashimoto, I., Nakano, Y., Ikeda, O., Aoyagi, Y., Matsuo, R., Fukunaga, K., Yasue, H. & Ohkohchi, N. (2009) Platelets contribute to the reduction of liver fibrosis in mice. J. Gastroenterol. Hepatol., 24, 78-89.